Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Arca Biopharma Inc (ABIO)

Arca Biopharma Inc (ABIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,086
  • Shares Outstanding, K 14,410
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,740 K
  • 60-Month Beta 2.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.73
Trade ABIO with:

Options Overview

Details
  • Implied Volatility 127.67%
  • Historical Volatility 28.67%
  • IV Percentile 17%
  • IV Rank 8.25%
  • IV High 560.92% on 12/07/20
  • IV Low 88.71% on 05/20/21
  • Put/Call Vol Ratio 0.12
  • Today's Volume 65
  • Volume Avg (30-Day) 119
  • Put/Call OI Ratio 2.24
  • Today's Open Interest 777
  • Open Int (30-Day) 1,531

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.86 +4.55%
on 08/23/21
3.17 -5.67%
on 09/03/21
+0.13 (+4.55%)
since 08/20/21
3-Month
2.72 +9.93%
on 07/19/21
3.84 -22.14%
on 07/29/21
-0.62 (-17.17%)
since 06/18/21
52-Week
2.72 +9.93%
on 07/19/21
5.50 -45.64%
on 02/11/21
-2.19 (-42.28%)
since 09/18/20

Most Recent Stories

More News
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that the...

ABIO : 2.99 (-3.55%)
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that Jeff...

ABIO : 2.99 (-3.55%)
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that it...

ABIO : 2.99 (-3.55%)
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported second quarter...

ABIO : 2.99 (-3.55%)
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that the...

ABIO : 2.99 (-3.55%)
ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today provided an update...

ABIO : 2.99 (-3.55%)
ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13th

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that Thomas...

ABIO : 2.99 (-3.55%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period...

ACOG.VN : 1.700 (-3.95%)
ACER : 2.52 (+2.44%)
ADXN : 9.35 (+1.19%)
AGRX : 1.0100 (-6.48%)
ATGN : 1.9100 (-2.55%)
ABIO : 2.99 (-3.55%)
AUUD : 2.45 (-8.92%)
BASA : 0.3300 (+0.03%)
BMRA : 4.38 (-5.81%)
BKTI : 2.82 (-5.69%)
BSFC : 6.4000 (+2.56%)
DTST : 4.75 (-9.87%)
DCTH : 8.86 (-2.85%)
DMIFF : 0.2079 (-5.50%)
DLPN : 12.20 (-1.29%)
FLUX : 6.60 (+3.45%)
GBNH : 8.47 (-4.29%)
HAVLF : 0.2283 (+0.35%)
ISDR : 25.99 (-4.34%)
INLB : 1.4900 (-5.70%)
KNWN : 2.3000 (-5.35%)
LXXGF : 0.3515 (-9.87%)
MKTY : 8.08 (-8.49%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0600 (+0.95%)
NEPH : 8.96 (-0.78%)
NMTC : 3.58 (-11.60%)
NLSP : 2.38 (-9.51%)
OBLG : 2.22 (-11.20%)
PBLA : 2.20 (+1.85%)
POSAF : 1.0000 (-1.96%)
PCSA : 7.32 (-7.46%)
PTIX : 1.8900 (-1.56%)
QOEG : 0.0853 (-14.70%)
QIPT : 5.62 (-2.77%)
SNGX : 1.0200 (-5.56%)
STRR : 2.51 (-5.99%)
TGCB : 0.6000 (-20.00%)
VERB : 1.7700 (-7.33%)
WTEQ.CN : 0.110 (-8.33%)
WINT : 1.9000 (+0.53%)
AYRO : 3.35 (-7.97%)
BCTX : 7.17 (-8.78%)
BTX : 9.96 (-16.65%)
HWAL : 1.7500 (unch)
NMRD : 6.11 (-11.19%)
THBRF : 3.4000 (-2.86%)
TRIQ : 0.7400 (-25.99%)
ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement

ARCA biopharma, Inc. (Nasdaq: ABIO) today announced it has entered into a patent assignment agreement with the University Medical Center of Johannes Gutenberg University Mainz, Germany. Under the agreement,...

ABIO : 2.99 (-3.55%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy is set for July 13-15, 2021. There will be 50+ companies conducting virtual presentations as well as private meetings with qualified...

ACOG.VN : 1.700 (-3.95%)
ACER : 2.52 (+2.44%)
ADXN : 9.35 (+1.19%)
AGRX : 1.0100 (-6.48%)
ATGN : 1.9100 (-2.55%)
ABIO : 2.99 (-3.55%)
AUUD : 2.45 (-8.92%)
BASA : 0.3300 (+0.03%)
BKTI : 2.82 (-5.69%)
BSFC : 6.4000 (+2.56%)
DTST : 4.75 (-9.87%)
DCTH : 8.86 (-2.85%)
DMIFF : 0.2079 (-5.50%)
DLPN : 12.20 (-1.29%)
FLUX : 6.60 (+3.45%)
GBNH : 8.47 (-4.29%)
HAVLF : 0.2283 (+0.35%)
ISDR : 25.99 (-4.34%)
INLB : 1.4900 (-5.70%)
KNWN : 2.3000 (-5.35%)
LXXGF : 0.3515 (-9.87%)
MKTY : 8.08 (-8.49%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0600 (+0.95%)
NEPH : 8.96 (-0.78%)
NMTC : 3.58 (-11.60%)
NLSP : 2.38 (-9.51%)
OBLG : 2.22 (-11.20%)
PBLA : 2.20 (+1.85%)
POSAF : 1.0000 (-1.96%)
PCSA : 7.32 (-7.46%)
PTIX : 1.8900 (-1.56%)
QOEG : 0.0853 (-14.70%)
QIPT : 5.62 (-2.77%)
SNGX : 1.0200 (-5.56%)
STRR : 2.51 (-5.99%)
TGCB : 0.6000 (-20.00%)
VERB : 1.7700 (-7.33%)
WTEQ.CN : 0.110 (-8.33%)
WINT : 1.9000 (+0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ARCA biopharma, Inc., a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases. It is positioned to bring personalized therapies for the treatment of cardiovascular disease, through the use of genetics. Complementing the Company's cardiovascular...

See More

Key Turning Points

3rd Resistance Point 3.17
2nd Resistance Point 3.12
1st Resistance Point 3.06
Last Price 2.99
1st Support Level 2.95
2nd Support Level 2.90
3rd Support Level 2.84

See More

52-Week High 5.50
Fibonacci 61.8% 4.44
Fibonacci 50% 4.11
Fibonacci 38.2% 3.78
Last Price 2.99
52-Week Low 2.72

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar